SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-346073
Filing Date
2012-08-09
Accepted
2012-08-09 10:48:44
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d357749d10q.htm 10-Q 425695
2 REPLIGEN CORPORATION NON-EMPLOYEE DIRECTORS' DEFERRED COMPENSATION PLAN d357749dex102.htm EX-10.2 13635
3 RULE 13A-14(A)/15D-14(A) CERTIFICATION d357749dex311.htm EX-31.1 6076
4 RULE 13A-14(A)/15D-14(A) CERTIFICATION d357749dex312.htm EX-31.2 6074
5 CEO AND CFO CERTIFICATION PURSUANT TO SECTION 906 d357749dex321.htm EX-32.1 7122
  Complete submission text file 0001193125-12-346073.txt   4155251

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rgen-20120630.xml EX-101.INS 598838
7 XBRL TAXONOMY EXTENSION SCHEMA rgen-20120630.xsd EX-101.SCH 41865
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgen-20120630_cal.xml EX-101.CAL 60432
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgen-20120630_def.xml EX-101.DEF 242977
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgen-20120630_lab.xml EX-101.LAB 344023
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgen-20120630_pre.xml EX-101.PRE 285451
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-14656 | Film No.: 121018992
SIC: 2836 Biological Products, (No Diagnostic Substances)